Long-Term Observation of Cyclosporine as Second-Line Therapy in Adults for Severe Acute Autoimmune Hepatitis

Hepatology. 2021 Jun;73(6):2594-2597. doi: 10.1002/hep.31597. Epub 2021 May 21.
No abstract available

MeSH terms

  • Acute Disease
  • Administration, Intravenous
  • Adult
  • Calcineurin Inhibitors / administration & dosage
  • Calcineurin Inhibitors / adverse effects
  • Cyclosporine* / administration & dosage
  • Cyclosporine* / adverse effects
  • Drug Monitoring / methods*
  • Female
  • Hepatitis, Autoimmune* / diagnosis
  • Hepatitis, Autoimmune* / drug therapy
  • Hepatitis, Autoimmune* / physiopathology
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Liver Function Tests / methods
  • Long-Term Care* / methods
  • Long-Term Care* / statistics & numerical data
  • Male
  • Retrospective Studies
  • Severity of Illness Index
  • Time
  • Treatment Outcome

Substances

  • Calcineurin Inhibitors
  • Immunosuppressive Agents
  • Cyclosporine